ROBERT ANG - 13 Sep 2022 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role: President and CEO, Director
Signature: /s/ Rich Segal, Attorney-in-Fact
Issuer symbol: VOR
Transactions as of: 13 Sep 2022
Net transactions value: $0
Form type: 4
Filing time: 15 Sep 2022, 16:18:11 UTC
Previous filing: 03 Feb 2022
Next filing: 08 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VOR	Common Stock	Award	$0	+172,500	+42%	$0.000000	584,572	13 Sep 2022	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	VOR	Employee Stock Option (right to buy)	Award	$0	+172,500		$0.000000	172,500	13 Sep 2022	Common Stock	172,500	$4.97	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the number of shares underlying restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest in four equal installments on each of March 1, 2023, September 1, 2023, March 1, 2024 and September 1, 2024, in each case, subject to the Reporting Person's continued service as of each such date.
F2	The shares shall vest and become exercisable in a series of 24 successive equal monthly installments beginning on October 1, 2022, in each case subject to the Reporting Person's continued service as of each such date.